Prof. Alkilany is a Professor of Pharmaceutics and Nanotechnology at Qatar University, where he also serves as the Research Coordinator for the College of Pharmacy. He earned his PhD from the University of Illinois in the USA and completed postdoctoral training at the University of Georgia.

With a robust background in pharmaceutical manufacturing, Prof. Alkilany has worked with renowned organizations, including Lilly in the USA and Hikma Pharmaceuticals in Jordan. His extensive industry experience has led to the development of over twenty products for regulated markets. Recently, Prof. Alkilany has developed Q-Silvano hydrogel, which has been officially registered by the Ministry of Public Health in Qatar and is manufactured by QLife Pharma. This marks the first nanotechnology-based medical product from Qatar University to enter the market.

Dr. Alkilany is highly regarded for his scholarly contributions to the field, boasting more than 75 publications that have garnered over 19,000 citations. His achievements have been recognized with the prestigious German AvH Fellowship, and he is listed among Stanford’s Top 2% Scientists globally.  His research primarily focuses on the development of nanomaterials for drug delivery and various biomedical applications.